Recombinant lactoferrin (Ventria Bioscience)

N/A

Report date: 2024/02/25 20:00:31

Base Information

Drug NameRecombinant lactoferrin (Ventria Bioscience)
Drug Alias NameVEN-100VEN-101VEN-120VEN-130VEN-140 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulatorsMacrophages stimulants
TargetsNot applicable
Therapy Area/IndicationsDiarrheaInflammationDiabetic Retinopathy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVentria Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins UniversityVentria Bioscience Inc
Active IndicationsN/A
Inactive IndicationsDiarrheaInflammationDiabetic Retinopathy +[4] 

Other Information

ATC CodeN/A
Related LinksN/A